Literature DB >> 16336574

Chronic kidney disease: a European perspective.

Norbert Lameire1, Kitty Jager, Wim Van Biesen, Dirk de Bacquer, Raymond Vanholder.   

Abstract

There is an exponential growth worldwide of patients with end-stage renal disease (ESRD). Prevalences, outcomes, and underlying causes of ESRD are relatively well documented through different organizations. It is, however, clear that a large part of the bad outcome of ESRD patients is due to deficient follow-up during the earlier chronic kidney disease (CKD) stages. Data on CKD, prevalence of the different stages, and the evolution to ESRD are rather scant, and available data are conflictive. This is at least partly due to the lack of an international standard for measurement of renal function. In addition, there is compiling evidence that presence of proteinuria, even with a normal renal function, predisposes to ESRD. Most authors now prefer the term "kidney injury" rather than "kidney failure" to indicate people at risk for evolution to ESRD or for complications of CKD. Detection of these patients at risk is important to implement measures to slow down progression of CKD and avoid secondary complications. As it is clear that most of these CKD patients die before they reach ESRD, it might be that by taking the necessary preventive measures, the number of ESRD patients might still further increase exponentially.

Entities:  

Mesh:

Year:  2005        PMID: 16336574     DOI: 10.1111/j.1523-1755.2005.09907.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  15 in total

1.  Use of Self-Organizing Maps for Balanced Scorecard analysis to monitor the performance of dialysis clinic chains.

Authors:  Isabella Cattinelli; Elena Bolzoni; Carlo Barbieri; Flavio Mari; José David Martin-Guerrero; Emilio Soria-Olivas; José Maria Martinez-Martinez; Juan Gomez-Sanchis; Claudia Amato; Andrea Stopper; Emanuele Gatti
Journal:  Health Care Manag Sci       Date:  2011-11-15

2.  Autophagy regulates TGF-β expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction.

Authors:  Yan Ding; Sung ll Kim; So-Young Lee; Ja Kun Koo; Zhibo Wang; Mary E Choi
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

3.  Beraprost sodium mitigates renal interstitial fibrosis through repairing renal microvessels.

Authors:  Shulin Li; Yanping Wang; Lu Chen; Zhuojun Wang; Guodong Liu; Bangjie Zuo; Caixia Liu; Dong Sun
Journal:  J Mol Med (Berl)       Date:  2019-03-28       Impact factor: 4.599

4.  TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis.

Authors:  Fernanda T Borges; Sonia A Melo; Berna C Özdemir; Noritoshi Kato; Ignacio Revuelta; Caroline A Miller; Vincent H Gattone; Valerie S LeBleu; Raghu Kalluri
Journal:  J Am Soc Nephrol       Date:  2012-12-28       Impact factor: 10.121

5.  Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury.

Authors:  Li Yang; Tatiana Y Besschetnova; Craig R Brooks; Jagesh V Shah; Joseph V Bonventre
Journal:  Nat Med       Date:  2010-05-02       Impact factor: 53.440

6.  Inflammatory mediators release in urine from mice injected with Crotalus durissus terrificus venom.

Authors:  A Hernández Cruz; L Barbosa Navarro; R Z Mendonça; V L Petricevich
Journal:  Mediators Inflamm       Date:  2011-11-29       Impact factor: 4.711

Review 7.  The roles of CD147 and/or cyclophilin A in kidney diseases.

Authors:  Xin Qu; Chunting Wang; Jicheng Zhang; Guoqiang Qie; Jianxin Zhou
Journal:  Mediators Inflamm       Date:  2014-12-17       Impact factor: 4.711

8.  An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.

Authors:  Susan R Sandeman; Carol A Howell; Gary J Phillips; Yishan Zheng; Guy Standen; Robert Pletzenauer; Andrew Davenport; Kolitha Basnayake; Owen Boyd; Stephen Holt; Sergey V Mikhalovsky
Journal:  J Mater Sci Mater Med       Date:  2014-02-27       Impact factor: 3.896

9.  Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis.

Authors:  Zhi-Hao Zhang; Feng Wei; Nosratola D Vaziri; Xian-Long Cheng; Xu Bai; Rui-Chao Lin; Ying-Yong Zhao
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

10.  Acute kidney injury in a patient with metabolic syndrome.

Authors:  Gioacchino Li Cavoli; Rita Passantino; Angelo Ferrantelli; Angelo Tralongo; Franca Servillo; Tancredi Vincenzo Li Cavoli; Pietro Tralongo; Mattia Palmeri; Giacomo Ferrantelli; Rotolo Ugo
Journal:  Bioimpacts       Date:  2015-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.